<p class="MarginalNote"><span class="wb-invisible">Marginal note:</span>Suspension and revocation</p><ul class="Section ProvisionList" id="1174069"><li><p class="Subsection" id="1174071"><strong><a class="sectionLabel" id="s-21.93"><span class="sectionLabel">21.93</span></a></strong> <span class="lawlabel">(1)</span> Subject to the regulations, the Minister may suspend or revoke an advanced therapeutic product licence, in whole or in part, if</p><ul class="ProvisionList"><li><p class="Paragraph" id="1174072"><span class="lawlabel">(a)</span> the Minister believes that the risks that are associated with the advanced therapeutic product outweigh the benefits;</p></li><li><p class="Paragraph" id="1174073"><span class="lawlabel">(b)</span> the Minister believes that the risks associated with the product or any authorized activity are not being adequately managed or controlled;</p></li><li><p class="Paragraph" id="1174074"><span class="lawlabel">(c)</span> in the case of a suspension, any prescribed circumstance exists; or</p></li><li><p class="Paragraph" id="1174075"><span class="lawlabel">(d)</span> in the case of a revocation, any prescribed circumstance exists.</p></li></ul></li><li><p class="MarginalNote"><span class="wb-invisible">Marginal note:</span>Suspension without prior notice</p><p class="Subsection" id="1174076"><span class="lawlabel">(2)</span> If the Minister believes that an immediate suspension is necessary to prevent injury to health, the Minister may suspend an advanced therapeutic product licence, in whole or in part, without prior notice to its holder and regardless of whether any of the circumstances referred to in subsection (1) exists.</p></li></ul><div class="HistoricalNote"><ul class="HistoricalNote"><li class="HistoricalNoteSubItem"><a href="#1156064-1174079" aria-controls="centred-popup" class="wb-lbx" role="button" data-ajax-after="1156064-1174079.html">2019, c. 29, s. 169</a></li></ul></div>
